XML 50 R33.htm IDEA: XBRL DOCUMENT v3.22.1
ASSETS IMPAIRMENTS AND RESTRUCTURING (Tables)
3 Months Ended
Mar. 31, 2022
Restructuring Costs and Asset Impairment Charges [Abstract]  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
The following table summarizes the changes in asset impairments and restructuring charges, the non-cash reductions attributable to asset impairments, and the cash reductions in restructuring reserves for severance costs and site closure costs paid in first three months 2022 and full year 2021:

(Dollars in millions)Balance at January 1, 2022Provision/ AdjustmentsNon-cash Reductions/
Additions
Cash ReductionsBalance at March 31, 2022
Non-cash charges$— $— $— $— $— 
Severance costs12 — — (2)10 
Other restructuring costs— (4)
Total$17 $$— $(6)$13 

(Dollars in millions)
Balance at January 1, 2021Provision/ AdjustmentsNon-cash Reductions/
Additions
Cash ReductionsBalance at December 31, 2021
Non-cash charges$— $16 $(16)$— $— 
Severance costs65 (1)(54)12 
Other restructuring costs14 29 (9)(29)
Total$79 $47 $(26)$(83)$17 
Restructuring and Related Costs [Table Text Block]
(Dollars in millions)First Quarter
Gain on Sale of Previously Impaired Assets20222021
Site optimizations
AFP - Animal nutrition (1)
$— $(1)
— (1)
Severance Charges
Site optimizations
AM - Advanced interlayers (2)
— 
— 
Other Restructuring Costs
CI & AFP - Singapore (3)
Site optimizations
AM - Advanced interlayers (2)
— 
Other - Tire additives (4)
— 
Total$$

(1)Fixed asset impairments, net in the AFP segment from the previously reported closure of an animal nutrition manufacturing facility in Asia Pacific as part of ongoing site optimization.
(2)Site closure costs in first quarter 2022 and severance costs in first quarter 2021 in the AM segment due to the previously reported closure of an advanced interlayers manufacturing facility in North America as part of ongoing site optimization. In addition, accelerated depreciation of $4 million was recognized in "Cost of sales" in the Unaudited Consolidated Statements of Earnings, Comprehensive Income and Retained Earnings in first quarter 2021 related to the closure of this facility.
(3)Site closure costs in first quarter 2022 of $1 million in the Chemical Intermediates ("CI") segment and site closure costs in first quarter 2021 of $4 million and $1 million in the CI and AFP segments, respectively, resulting from closure of the Singapore manufacturing site.
(4)Site closure costs in "Other" from the previously reported closure of a tire additives manufacturing facility in Asia Pacific as part of ongoing site optimization.